(0.32%) 5 116.33 points
(0.31%) 38 357 points
(0.37%) 15 988 points
(-0.97%) $83.04
(5.36%) $2.03
(0.33%) $2 355.00
(0.54%) $27.69
(4.26%) $961.35
(-0.27%) $0.932
(-0.45%) $10.98
(-0.59%) $0.796
(1.63%) $93.37
Live Chart Being Loaded With Signals
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions...
Stats | |
---|---|
本日の出来高 | 197 968 |
平均出来高 | 0.00 |
時価総額 | 10.40M |
EPS | $-0.999 ( 2023-11-01 ) |
次の収益日 | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.120 |
ATR14 | $0.303 (22.44%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-16 | Naseem Rao Haris | Buy | 1 000 000 | Stock Option (Right to Buy) |
2023-09-07 | Naseem Rao Haris | Buy | 0 | Common Stock |
2023-08-28 | Summus Holdings Llc | Sell | 0 | Common Stock |
2023-08-28 | Soon-shiong Patrick | Buy | 537 272 | Common Stock |
2023-08-28 | Soon-shiong Patrick | Buy | 15 384 616 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 97 transactions |
Buy: 88 503 201 | Sell: 27 090 358 |
ボリューム 相関
NantHealth Inc 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
NantHealth Inc 相関 - 通貨/商品
NantHealth Inc 財務諸表
Annual | 2022 |
収益: | $67.00M |
総利益: | $38.16M (56.96 %) |
EPS: | $-8.80 |
FY | 2022 |
収益: | $67.00M |
総利益: | $38.16M (56.96 %) |
EPS: | $-8.80 |
FY | 2021 |
収益: | $62.65M |
総利益: | $34.84M (55.61 %) |
EPS: | $-7.66 |
FY | 2020 |
収益: | $73.17M |
総利益: | $15.76M (21.54 %) |
EPS: | $-7.63 |
Financial Reports:
No articles found.
NantHealth Inc
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。